StockNews.com initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report published on Saturday. The firm issued a sell rating on the stock. Separately, HC Wainwright restated a buy rating and set a $3.00 target price on shares of Moleculin Biotech in a research note on Thursday, December 14th. View Our […]
StockNews.com initiated coverage on shares of SuperCom (NASDAQ:SPCB – Free Report) in a report published on Saturday morning. The firm issued a sell rating on the industrial products company’s stock. SuperCom Stock Performance Shares of SPCB opened at $0.18 on Friday. SuperCom has a fifty-two week low of $0.16 and a fifty-two week high of […]
StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report released on Saturday. The brokerage issued a sell rating on the stock. Ampio Pharmaceuticals Stock Down 2.3 % AMPE opened at $1.67 on Friday. Ampio Pharmaceuticals has a twelve month low of $1.56 and a twelve month high of $8.30. […]
StockNews.com assumed coverage on shares of Sirius XM (NASDAQ:SIRI – Free Report) in a research report report published on Saturday morning. The brokerage issued a hold rating on the stock. Other equities analysts also recently issued reports about the stock. Wells Fargo & Company reissued an underweight rating and set a $4.50 target price (down […]
StockNews.com started coverage on shares of EchoStar (NASDAQ:SATS – Free Report) in a research note released on Saturday morning. The firm issued a buy rating on the communications equipment provider’s stock. Several other research firms have also recently weighed in on SATS. Raymond James reduced their price objective on EchoStar from $54.00 to $37.00 and […]